4
Changes in Ownership
Arcturus Therapeutics Holdings Inc. Filed Acc 0001209191-21-051182
Director sold 800,000 shares at an average $54.54 ($43,631,250)
From the SEC's structured data for this filing
Trades in this filing
Ultragenyx Pharmaceutical Inc. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-10 | Sale : show line 1 in the form | −725,000 | $55.44 | $40,194,000 | 1,475,000 | D |
| 2021-08-11 | Sale : show line 2 in the form | −75,000 | $45.83 | $3,437,250 | 1,400,000 | D |
| Open-market sales · 800,000 sh · avg $54.54 · $43,631,250 | ||||||
Loading xslF345X03/doc4.xml…